Toward Precision Cardio-Oncology in Breast Radiotherapy - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Advancing Precision Cardio-Oncology in Breast Cancer Radiotherapy

  • By

  • Avirup Guha

  • September 2, 2026

Share

Clinical Report: Advancing Precision Cardio-Oncology in Breast Cancer Radiotherapy

Background

Radiotherapy is essential in breast cancer treatment, significantly reducing recurrence and mortality rates. However, as survival rates improve, cardiovascular disease has become a major concern for breast cancer survivors, as noted in recent studies. Understanding the relationship between radiotherapy and cardiovascular risk is crucial for optimizing patient outcomes.

Data Highlights

Risk Factors8-Year Cumulative Incidence of IHDAdjusted Hazard Ratio
Left-Sided Treatment20.3%1.37
Right-Sided Treatment15.2%Not reported

Key Findings

  • Left-sided radiotherapy is associated with a higher risk of IHD compared to right-sided treatment.
  • The 8-year cumulative incidence of IHD is significantly higher in patients with 3 or more cardiovascular risk factors.
  • Contemporary studies suggest that average cardiovascular harm from left-sided treatment has declined over time, but this requires further investigation.
  • The study introduces a 6-item cardiovascular risk burden score to assess patient vulnerability.

Clinical Implications

Clinicians should assess cardiovascular risk factors in patients undergoing breast radiotherapy to tailor treatment plans effectively.

Conclusion

The findings emphasize the need for cardiovascular risk assessment in breast cancer radiotherapy planning.

Related Resources & Content

  1. Chung and Noh, JAMA Network Open, 2026 -- Laterality of Breast Radiotherapy and Ischemic Heart Disease by Cardiovascular Risk Burden
  2. American Heart Association, PubMed, 2026 -- Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement
  3. ASTRO, PubMed, 2026 -- Dose-Volume Histogram Compendium of Dose Constraints for Treatment Planning
  4. ASTRO-ASCO-SSO, PubMed, 2026 -- Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline
  5. the asco post — Cardio-Oncology Is a Growing Subspecialty, but Where Are the Oncologists?
  6. the asco post — Accelerated Radiation Therapies Move Forward in Early Breast Cancer
  7. The ASCO Post — Reducing Incidental Cardiac Irradiation during Breast Radiotherapy
  8. The ASCO Post — Breast Cancer Radiotherapy Leads to Moderate Cardiac Function Decline Over Years
  9. Cardio-Oncology Is a Growing Subspecialty, but Where Are the Oncologists?
  10. Accelerated Radiation Therapies Move Forward in Early Breast Cancer
  11. Reducing Incidental Cardiac Irradiation during Breast Radiotherapy
  12. Coronary Atherosclerosis in Patients With Cancer and Survivors: A Scientific Statement From the American Heart Association - PubMed
  13. Dose-Volume Histogram Compendium of Dose Constraints for Treatment Planning: An ASTRO Consensus Paper - PubMed
  14. Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline - PubMed
  15. Concurrent Versus Sequential Radiation Dose Escalation to the Surgical Cavity for Conservative Treatment of High-Risk Early Breast Cancer: NRG/RTOG 1005 Phase III Trial | Journal of Clinical Oncology
  16. Deep inspiration breath hold versus free breathing in postoperative radiotherapy strategy for patients with left-sided breast cancer treated with volumetric modulated arc therapy: A meta-analysis and systematic review - PubMed
  17. Laterality of Breast Radiotherapy and Ischemic Heart Disease by Cardiovascular Risk Burden | Oncology | JAMA Network Open | JAMA Network

Original Source(s)

Related Content